42382-46-7 Usage
Uses
Used in Organic Synthesis:
5-Pyrimidinamine, 2-(methylthio)(9CI) is used as a building block in organic synthesis for the creation of more complex molecules. Its unique structure with a sulfur-containing group can facilitate the formation of various chemical entities, contributing to the development of novel compounds with specific functionalities.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-Pyrimidinamine, 2-(methylthio)(9CI) is used as a potential active pharmaceutical ingredient (API). Its structure may offer therapeutic benefits, and further research could reveal its potential in treating specific diseases or conditions. 5-Pyrimidinamine, 2-(methylthio)(9CI)'s properties may be harnessed to develop new drugs or improve existing ones.
Used in Agrochemicals:
5-Pyrimidinamine, 2-(methylthio)(9CI) may also find applications in the agrochemical sector, where it could be utilized as a component in the development of pesticides, herbicides, or other crop protection agents. Its chemical properties might contribute to the effectiveness of these products, enhancing agricultural productivity and crop protection.
Further research is essential to explore the specific applications and potential of 5-Pyrimidinamine, 2-(methylthio)(9CI) in these industries, as well as to assess any associated risks or hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 42382-46-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,3,8 and 2 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 42382-46:
(7*4)+(6*2)+(5*3)+(4*8)+(3*2)+(2*4)+(1*6)=107
107 % 10 = 7
So 42382-46-7 is a valid CAS Registry Number.
42382-46-7Relevant academic research and scientific papers
GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
-
Page/Page column 57, (2009/12/28)
Compounds of Formula I wherein R1, R2, X, and Y are as defined herein, or a tautomer, optical isomer, prodrug, co-crystal, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
